Selected research
Industry Growth & Trends
Global Liver Cirrhosis Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Liver Cirrhosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Liver Cirrhosis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Liver Cirrhosis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Liver Cirrhosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Liver Cirrhosis market include Johnson & Johnson, Merck, GlaxoSmithKline, Bristol-Myers Squibb, Intercept Pharmaceuticals, Instituto Grifols, Gwo Xi Stem Cell Applied Technology, Gilead Sciences and F Hoffman La-Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Liver Cirrhosis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Liver Cirrhosis market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Liver Cirrhosis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Liver Cirrhosis.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Liver Cirrhosis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Liver Cirrhosis Market by Company
Johnson & Johnson
Merck
GlaxoSmithKline
Bristol-Myers Squibb
Intercept Pharmaceuticals
Instituto Grifols
Gwo Xi Stem Cell Applied Technology
Gilead Sciences
F Hoffman La-Roche
Conatus Pharmaceuticals
Liver Cirrhosis Segment by Type
Cryptogenic Cirrhosis
Cardiac Cirrhosis
Atrophic Cirrhosis
Alcoholic Cirrhosis
Biliary Cirrhosis
Liver Cirrhosis Segment by Application
Hospitals
Specialty Clinics
Liver Cirrhosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liver Cirrhosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liver Cirrhosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liver Cirrhosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Liver Cirrhosis companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cryptogenic Cirrhosis
- Cardiac Cirrhosis
- Atrophic Cirrhosis
- Alcoholic Cirrhosis
- Biliary Cirrhosis
Applications
- Hospitals
- Specialty Clinics
Companies covered
- Johnson & Johnson
- Merck
- GlaxoSmithKline
- Bristol-Myers Squibb
- Intercept Pharmaceuticals
- Instituto Grifols
- Gwo Xi Stem Cell Applied Technology
- Gilead Sciences
- F Hoffman La-Roche
- Conatus Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Liver Cirrhosis Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Liver Cirrhosis Market Size by Region (2021-2032)
- 1.4.1 Global Liver Cirrhosis Market Size by Region (2021-2026)
- 1.4.2 Global Liver Cirrhosis Market Size by Region (2027-2032)
- 1.5 Key Regions Liver Cirrhosis Market Size (2021-2032)
- 1.5.1 North America Liver Cirrhosis Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Liver Cirrhosis Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Liver Cirrhosis Market Size Growth Rate (2021-2032)
- 1.5.4 South America Liver Cirrhosis Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Liver Cirrhosis Market Size Growth Rate (2021-2032)
2 Liver Cirrhosis Market by Type
- 2.1 Type Introduction
- 2.1.1 Cryptogenic Cirrhosis
- 2.1.2 Cardiac Cirrhosis
- 2.1.3 Atrophic Cirrhosis
- 2.1.4 Alcoholic Cirrhosis
- 2.1.5 Biliary Cirrhosis
- 2.2 Global Liver Cirrhosis Market Size by Type
- 2.2.1 Global Liver Cirrhosis Market Size Overview by Type (2021-2032)
- 2.2.2 Global Liver Cirrhosis Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Liver Cirrhosis Market Size Forecasted by Type (2027-2032)
- 2.3 Global Liver Cirrhosis Market Size by Regions
- 2.3.1 North America Liver Cirrhosis Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Liver Cirrhosis Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Liver Cirrhosis Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Liver Cirrhosis Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Liver Cirrhosis Market Size Breakdown by Type (2021-2026)
3 Liver Cirrhosis Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Specialty Clinics
- 3.2 Global Liver Cirrhosis Market Size by Application
- 3.2.1 Global Liver Cirrhosis Market Size Overview by Application (2021-2032)
- 3.2.2 Global Liver Cirrhosis Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Liver Cirrhosis Market Size Forecasted by Application (2027-2032)
- 3.3 Global Liver Cirrhosis Market Size by Regions
- 3.3.1 North America Liver Cirrhosis Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Liver Cirrhosis Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Liver Cirrhosis Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Liver Cirrhosis Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Liver Cirrhosis Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Liver Cirrhosis Industry Trends
- 4.2 Liver Cirrhosis Industry Drivers
- 4.3 Liver Cirrhosis Industry Opportunities and Challenges
- 4.4 Liver Cirrhosis Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Liver Cirrhosis Revenue (2021-2026)
- 5.2 Global Liver Cirrhosis Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Liver Cirrhosis Key Company Headquarters & Area Served
- 5.4 Global Liver Cirrhosis Company, Product Type & Application
- 5.5 Global Liver Cirrhosis Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Liver Cirrhosis Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Liver Cirrhosis Players Market Share by Revenue in 2025
- 5.6.3 2025 Liver Cirrhosis Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Johnson & Johnson
- 6.1.1 Johnson & Johnson Company Information
- 6.1.2 Johnson & Johnson Business Overview
- 6.1.3 Johnson & Johnson Liver Cirrhosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Johnson & Johnson Liver Cirrhosis Product Portfolio
- 6.1.5 Johnson & Johnson Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Liver Cirrhosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Merck Liver Cirrhosis Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 GlaxoSmithKline
- 6.3.1 GlaxoSmithKline Company Information
- 6.3.2 GlaxoSmithKline Business Overview
- 6.3.3 GlaxoSmithKline Liver Cirrhosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 GlaxoSmithKline Liver Cirrhosis Product Portfolio
- 6.3.5 GlaxoSmithKline Recent Developments
- 6.4 Bristol-Myers Squibb
- 6.4.1 Bristol-Myers Squibb Company Information
- 6.4.2 Bristol-Myers Squibb Business Overview
- 6.4.3 Bristol-Myers Squibb Liver Cirrhosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Bristol-Myers Squibb Liver Cirrhosis Product Portfolio
- 6.4.5 Bristol-Myers Squibb Recent Developments
- 6.5 Intercept Pharmaceuticals
- 6.5.1 Intercept Pharmaceuticals Company Information
- 6.5.2 Intercept Pharmaceuticals Business Overview
- 6.5.3 Intercept Pharmaceuticals Liver Cirrhosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Intercept Pharmaceuticals Liver Cirrhosis Product Portfolio
- 6.5.5 Intercept Pharmaceuticals Recent Developments
- 6.6 Instituto Grifols
- 6.6.1 Instituto Grifols Company Information
- 6.6.2 Instituto Grifols Business Overview
- 6.6.3 Instituto Grifols Liver Cirrhosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Instituto Grifols Liver Cirrhosis Product Portfolio
- 6.6.5 Instituto Grifols Recent Developments
- 6.7 Gwo Xi Stem Cell Applied Technology
- 6.7.1 Gwo Xi Stem Cell Applied Technology Company Information
- 6.7.2 Gwo Xi Stem Cell Applied Technology Business Overview
- 6.7.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Product Portfolio
- 6.7.5 Gwo Xi Stem Cell Applied Technology Recent Developments
- 6.8 Gilead Sciences
- 6.8.1 Gilead Sciences Company Information
- 6.8.2 Gilead Sciences Business Overview
- 6.8.3 Gilead Sciences Liver Cirrhosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Gilead Sciences Liver Cirrhosis Product Portfolio
- 6.8.5 Gilead Sciences Recent Developments
- 6.9 F Hoffman La-Roche
- 6.9.1 F Hoffman La-Roche Company Information
- 6.9.2 F Hoffman La-Roche Business Overview
- 6.9.3 F Hoffman La-Roche Liver Cirrhosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 F Hoffman La-Roche Liver Cirrhosis Product Portfolio
- 6.9.5 F Hoffman La-Roche Recent Developments
- 6.10 Conatus Pharmaceuticals
- 6.10.1 Conatus Pharmaceuticals Company Information
- 6.10.2 Conatus Pharmaceuticals Business Overview
- 6.10.3 Conatus Pharmaceuticals Liver Cirrhosis Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Conatus Pharmaceuticals Liver Cirrhosis Product Portfolio
- 6.10.5 Conatus Pharmaceuticals Recent Developments
7 North America
- 7.1 North America Liver Cirrhosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Liver Cirrhosis Market Size by Country (2021-2026)
- 7.3 North America Liver Cirrhosis Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Liver Cirrhosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Liver Cirrhosis Market Size by Country (2021-2026)
- 8.3 Europe Liver Cirrhosis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Liver Cirrhosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Liver Cirrhosis Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Liver Cirrhosis Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Liver Cirrhosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Liver Cirrhosis Market Size by Country (2021-2026)
- 10.3 South America Liver Cirrhosis Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Liver Cirrhosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Liver Cirrhosis Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Liver Cirrhosis Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst